Sugi Predict

Sugi Predict / Targets / SKIC3

SKIC3

Superkiller complex protein 3 · Q6PGP7 · SKIC3 on Sugi Atlas →

0 patent compounds predicted against SKIC3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SKIC3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients PHASE3COMPLETED
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Oral Nitrite for Older Heart Failure Patients PHASE2COMPLETED
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer PHASE1/PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Consequences of Mutations in the SPG7 Gene at the Heterozygous State nanCOMPLETED
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SKIC3 binder may also engage these)

ProteinNameSimilarity
F8VPK0 — 1.000 F8VPK0 →
GTF3C3 General transcription factor 3C polypeptide 3 0.983 landscape →
Q6DFB8 — 0.983 Q6DFB8 →
B3DNN5 — 0.979 B3DNN5 →
Q6TGY8 — 0.976 Q6TGY8 →
CDC23 Cell division cycle protein 23 homolog 0.976 landscape →
ANAPC7 Anaphase-promoting complex subunit 7 0.975 landscape →
Q5R882 — 0.974 Q5R882 →
Q5E993 — 0.974 Q5E993 →
Q9WVM3 — 0.972 Q9WVM3 →
Q8BGZ4 — 0.972 Q8BGZ4 →
Q9CRD2 — 0.971 Q9CRD2 →
P49754 — 0.971 P49754 →
Q5KU39 — 0.971 Q5KU39 →
Q13702 — 0.970 Q13702 →
Q1JQ97 — 0.970 Q1JQ97 →
Q5ZIW2 — 0.970 Q5ZIW2 →
Q8VY89 — 0.970 Q8VY89 →
B0BNG0 — 0.970 B0BNG0 →
Q5F3K0 — 0.970 Q5F3K0 →
Q8BH15 — 0.969 Q8BH15 →
Q6N069 — 0.969 Q6N069 →
A7MB89 — 0.969 A7MB89 →
Q8CEF1 — 0.968 Q8CEF1 →
A5HK05 — 0.968 A5HK05 →
Q8C1Z7 — 0.968 Q8C1Z7 →
Q08CL8 — 0.968 Q08CL8 →
Q80UM3 — 0.968 Q80UM3 →
Q91W86 — 0.968 Q91W86 →
A1A4R8 — 0.967 A1A4R8 →